Compression Stockings for Treating Vasovagal Syncope Trial
NCT05086679 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 268
Last updated 2022-04-15
Summary
Syncope, a sudden, transient loss of consciousness (TLOC), is a common inconvenience of daily function and quality of life (QoL). The vasovagal syncope (VVS) is the most common type of syncope, which central and peripheral stimuli may trigger syncope by decreasing peripheral vascular resistance, bradycardia, or both. The venous return to the heart is one of these triggers which its reduction may occur due to prolonged standing, hot environment, hypovolemia, or redistribution of blood volume. The compression stockings may reduce syncopal episodes by increasing venous return. Although the use of compression stockings was never assessed in clinical trials, it could be a possible treatment for decreasing VVS recurrences.
Conditions
- Syncope, Vasovagal
Interventions
- DEVICE
-
Compression Stockings with 25-30 mm Hg pressure
The group will have compression stockings with 25-30 mm Hg pressure. All the participants' size for compression stocking will be measured at the first visit. Three points will be measured: below and above their knees and above their ankle. Subsequently, Right Arian Farmed Co (Tehran, Iran) will provide compression stockings for patients based on their sizes. Participants will be asked to use compression stockings as long as they could (ideal would be the majority of the time they are upright). In addition, a CD included some videos and booklets about instructions on how to wear CS and how to keep them will be provided for the participants with their compression stockings.
- DEVICE
-
Compression stockings with up to <=10 mm Hg pressure
The group will have compression stockings with up to 10 mm Hg pressure. All the participants' size for compression stocking will be measured at the first visit. Three points will be measured: below and above their knees and above their ankle. Subsequently, Right Arian Farmed Co (Tehran, Iran) will provide compression stockings for patients based on their sizes. Participants will be asked to use compression stockings as long as they could (ideal would be the majority of the time they are upright). In addition, a CD included some videos and booklets about instructions on how to wear CS and how to keep them will be provided for the participants with their compression stockings.
- BEHAVIORAL
-
Lifestyle modification
All patients will receive standard treatment of VVS despite their randomization(drink 2-3 liters of fluids, consume 10 grams 120 mmol/day of sodium chloride, and practice counter-pressure maneuvers (squatting, leg crossing, handgrip, and arm-tensing))
Sponsors & Collaborators
-
Tehran Arrhythmia Center
collaborator UNKNOWN -
Rajaie Cardiovascular Medical and Research Center
collaborator OTHER -
Imam Khomeini Hospital
collaborator OTHER -
Isfahan University of Medical Sciences
collaborator OTHER -
Ahvaz Jundishapur University of Medical Sciences
collaborator OTHER -
Guilan University of Medical Sciences
collaborator OTHER -
Tehran Heart Center
lead OTHER
Principal Investigators
-
Hamed Tavolinejad, MD · Tehran Heart Center, Tehran University of Medical Sciences
-
Amirhossein Poopak, MD · Tehran Heart Center, Tehran University of Medical Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-14
- Primary Completion
- 2024-10-10
- Completion
- 2024-12-10
Countries
- Iran
Study Locations
More Related Trials
-
Creation of a Syncope Channel for Patients Admitted to the Emergency Department for Loss of Consciousness and Not Hospitalized: Etiological Predictivity (Before/After Study)
NCT06503653 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Global Approach to Faint and Falls
NCT05752682 ·Status: RECRUITING
-
Stop Vasodepressor Drugs in Reflex Syncope
NCT02137278 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Yoga in Patients With Neurocardiogenic Syncope
NCT01695525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Practical Approaches to Care in Emergency Syncope
NCT04533425 ·Status: COMPLETED
-
Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
NCT05729724 ·Status: COMPLETED
-
Effect of Psychotherapy on Quality of Life and Recurrence of Events in Patients With Recurrent Vasovagal Syncope: A Randomized Pilot Study
NCT04252729 ·Status: COMPLETED ·Phase: NA
-
In Hospital 24 Hour Observation of Syncope Patients
NCT06472375 ·Status: RECRUITING
-
Evaluating an Emergency Department Observation Syncope Protocol for Older Adults
NCT01003262 ·Status: COMPLETED ·Phase: NA
-
Improving Syncope Risk Stratification in Older Adults
NCT01802398 ·Status: COMPLETED
-
Evaluation of the Efficiency of Hydration by Isotonic Solution in the Prevent of the Fainting Whole Blood Donors
NCT02075099 ·Status: COMPLETED ·Phase: NA
-
Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury
NCT02012582 ·Status: COMPLETED ·Phase: PHASE2
-
A Low ChloridE hyperTonic Solution for Brain Edema
NCT03204955 ·Status: COMPLETED ·Phase: PHASE1
-
CSRS Implementation - A Pilot Study
NCT04790058 ·Status: ACTIVE_NOT_RECRUITING
-
Temperature Response to a Head-Neck Cooling System
NCT00025987 ·Status: COMPLETED ·Phase: PHASE1
-
SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
NCT04972071 ·Status: RECRUITING ·Phase: NA
-
Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope
NCT00143754 ·Status: TERMINATED ·Phase: PHASE3
-
Impact of Blood Phobia on Fainting Susceptibility
NCT06336031 ·Status: RECRUITING ·Phase: NA
-
The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
NCT04972123 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled Nitric Oxide in Brain Injury
NCT03260569 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Nitric Oxide for Microvascular Dysfunction in Traumatic Brain Injury
NCT05616910 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
NCT06265259 ·Status: RECRUITING ·Phase: PHASE4
-
Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations
NCT00302900 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Laboratory Characteristics of Patients Admitted With Syncope; Diagnosis and Follow up After These Patients
NCT01201993 ·Status: SUSPENDED
-
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
NCT06282965 ·Status: RECRUITING ·Phase: PHASE1/PHASE2